Cover Image

Safety and efficacy of ibrutinib in a patient with severe renal impairment

Kalman Filanovsky, Lev Shvidel
  • Kalman Filanovsky
    Kaplan Medical Center, Rehovot; Hadassah and Hebrew University Medical School, Jerusalem, Israel | fikalman@yahoo.com
  • Lev Shvidel
    Kaplan Medical Center, Rehovot; Hadassah and Hebrew University Medical School, Jerusalem, Israel

Abstract

Not available

Keywords

Lymphoma, Ibrutinib, chronic renal failure

Full Text:

PDF
HTML
Submitted: 2017-02-04 16:06:23
Published: 2017-09-26 14:30:18
Search for citations in Google Scholar
Related articles: Google Scholar
Abstract views:
304

Views:
PDF
108
HTML
96

Article Metrics

Metrics Loading ...

Metrics powered by PLOS ALM


Copyright (c) 2017 Kalman Filanovsky, Lev Shvidel

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
 
© PAGEPress 2008-2018     -     PAGEPress is a registered trademark property of PAGEPress srl, Italy.     -     VAT: IT02125780185     •     Privacy